Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-04

Clinical Trial Update: Drug-drug Interaction Study of Gepotidacin [Phase 1]

View source ↗

Summary

Phase 1 study assessing drug-drug interactions for gepotidacin; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • gep totidacin (gepotidacin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 1 | Status: COMPLETED | Results posted: 2022-03-04